Molecular determinants of response to PI3K/AKT/mTOR and KRAS pathways inhibitors in NSCLC cell lines: Am J Cancer Res. 2020; 10(12): 4488-4497
Mario Negri Institute for Pharmacological Research
Indexed incrossrefpubmed
Abstract
[This corrects the article on p. 4488 in vol. 10, PMID: 33415013.].
Citation impact
4
total citations
- FWCI
- 0.00
- Percentile
- 95%
- References
- 40
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- KRAS
- PI3K/AKT/mTOR pathway
- MAPK/ERK pathway
- Protein kinase B
- Cancer research
- Cancer
- Medicine
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.